Page last updated: 2024-09-03

2',2'-difluorodeoxycytidine 5'-triphosphate and Lung Neoplasms

2',2'-difluorodeoxycytidine 5'-triphosphate has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, L; Kim, WY; Zhang, Y1
Goh, BC; Holford, NH; Lee, HS; Lee, SC; Soo, RA; Tham, LS; Wang, LZ1

Other Studies

2 other study(ies) available for 2',2'-difluorodeoxycytidine 5'-triphosphate and Lung Neoplasms

ArticleYear
Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy.
    Biomaterials, 2013, Volume: 34, Issue:13

    Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytidine Triphosphate; Enzyme Activation; Female; Humans; Lipids; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Pancreatic Neoplasms; Particle Size; Phosphates; Poly(ADP-ribose) Polymerases; Polyethylene Glycols; S Phase; Static Electricity; Xenograft Model Antitumor Assays

2013
Does saturable formation of gemcitabine triphosphate occur in patients?
    Cancer chemotherapy and pharmacology, 2008, Volume: 63, Issue:1

    Topics: Adipose Tissue; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Body Weight; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Creatinine; Cytidine Triphosphate; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Models, Biological; Prodrugs; Prospective Studies; Randomized Controlled Trials as Topic

2008